Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bunge Ltd    BG   BMG169621056


Delayed Quote. Delayed Nyse - 12/19 04:07:17 pm
90.39 USD   -1.46%
12/04 BUNGE : to Webcast Investor Day Presentations
12/04 BUNGE : Declares Dividends on Common and Preference Shares
12/02 BUNGE : to Webcast Investor Day Presentations
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summary4-Traders Strategies 

Bunge Ltd : We anticipate a reversal

02/14/2013 | 05:21am
Opinion : Bullish above USD 72
Target price : USD 79.9 Potential: 8.84%
Stop loss: USD 69.3
Food Processing

The upward trend could come to support Bunge in the coming sessions.

Moreover, at current price, the company is trading 9.78 times its earnings for this year and thus has a significant potential.

Bunge share price is in bullish trend in the medium and long term. In weekly data, moving averages are well-oriented. In the present configuration, the process is very gradual; however, prices have just begun a consolidation phase. The stock is now near the USD 72 short term support and the 100-day moving average. This should catapult the security toward the USD 79.9 resistance.

The most active investors can buy the share in the USD 72 support area and target a return toward USD 79.9. A stop loss can be placed under the USD 72 support.

Bunge Ltd : Bunge Ltd : We anticipate a reversal

© 2013

Disclaimer: is a website published by SURPERFORMANCE SAS. Surperformance or is not a registered broker-dealer nor a registered investment adviser. You understand that this web site and its content is furnished for your personal, noncommercial, informational purposes only, and that no mention of a particular security in this website constitutes a recommendation to buy, sell, or hold any other security, nor that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Surperformance and services will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. Information regarding trading and investment as provided by Surperformance professional is not tailored to the investment needs of any specific person. You acknowledge that you are responsible for your own financial decisions and should seek a registered financial agent depending on your own risk tolerance to advise you on your personal trading activities.

Financial Ratios

Size 2014e 2015e
Capitalization 13 124 M$ -
Entreprise Value (EV) 17 386 M$ 16 934 M$
Valuation 2014e 2015e
PER (Price / EPS) 15,5x 12,8x
Capitalization / Revenue 0,22x 0,21x
EV / Revenue 0,29x 0,27x
EV / EBITDA 8,68x 7,41x
Yield (DPS / Price) 1,41% 1,50%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 2,28% 2,59%
operating Leverage (Delta EBIT / Delta Sales) - 7,50x
Net Margin (Net Profit / Revenue) 1,41% 1,74%
ROA (Net Profit / Asset) 3,72% 4,43%
ROE (Net Profit / Equities) 8,64% 9,81%
Rate of Dividend 21,9% 19,1%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   1,51% 1,51%
Cash Flow / Sales (Taux d'autofinancement) 1,68% 2,03%
Capital Intensity (Assets / Sales) 0,38x 0,39x
Financial Leverage (Net Debt / EBITDA) 2,13x 1,67x
Income Statement Evolution
More Financials
EPS Revisions
Dynamic quotes